Micafungin Inhibits Dengue Virus Infection through the Disruption of Virus Binding, Entry, and Stability
Dengue fever is an arbovirus disease caused by infection with the dengue virus (DENV). Half of the world’s population lives under the threat of dengue fever, however, researchers have yet to develop any drugs that are clinically applicable to this infection. Micafungin is a member of the echinocandi...
| Main Authors: | Yen-Chen Chen, Jeng-Wei Lu, Chia-Tsui Yeh, Te-Yu Lin, Feng-Cheng Liu, Yi-Jung Ho |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-04-01
|
| Series: | Pharmaceuticals |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/14/4/338 |
Similar Items
-
A case of Candida glabrata severe urinary sepsis successfully treated with micafungin
by: Filippo Pieralli, et al.
Published: (2014-07-01) -
Pharmacology and metabolism of anidulafungin, caspofungin and micafungin in the treatment of invasive candidosis - review of the literature
by: Kofla G, et al.
Published: (2011-04-01) -
Antiviral Activity of Micafungin and Its Derivatives against SARS-CoV-2 RNA Replication
by: Shogo Nakajima, et al.
Published: (2023-02-01) -
Candida glabrata hospital isolate from Lebanon reveals micafungin resistance associated with increased chitin and resistance to a cell-surface-disrupting agent
by: Nour Fattouh, et al.
Published: (2024-06-01) -
Tizoxanide Antiviral Activity on Dengue Virus Replication
by: Kristie A. Yamamoto, et al.
Published: (2023-03-01)